Nanoparticle Albumin Bound Paclitaxel in the Third-Line Treatment of Recurrent Small Cell Lung Cancer in Real-World Practice: A Single Center Experience

Conclusions: As a single-agent third-line treatment for patients with relapsed SCLC, Nab-P was effective and safe.PMID:34657492 | DOI:10.1177/15330338211050775

Source: Technology in Cancer Research and Treatment - October 18, 2021 Category: Cancer & Oncology Authors: Yuchao Wang Li Li Chunhua Xu Source Type: research